Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Greater Europe Investment Trust Regulatory News (BRGE)

Share Price Information for BlackRock Greater Europe Investment Trust (BRGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 614.00
Bid: 611.00
Ask: 613.00
Change: 4.00 (0.66%)
Spread: 2.00 (0.327%)
Open: 610.00
High: 614.00
Low: 609.00
Prev. Close: 610.00
BRGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction : Portfolio Update

18 Nov 2020 15:34

BlackRock Greater Europe Investment Trust Plc - Correction : Portfolio Update

BlackRock Greater Europe Investment Trust Plc - Correction : Portfolio Update

PR Newswire

London, November 18

THIS ANNOUNCEMENT IS A CORRECTION: The cumulative share price and NAVperformance figures as at 31 October 2020 as released on 16 November 2020 havebeen updated.

The information contained in this release was correct as at 31 October 2020. Information on the Company’s up to date net asset values can be found on the London Stock Exchange website at:

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html

BLACKROCK GREATER EUROPE INVESTMENT TRUST PLC (LEI - 5493003R8FJ6I76ZUW55)

All information is at 31 October 2020 and unaudited.Performance at month end with net income reinvested 

One MonthThree MonthsOne YearThree YearsLaunch (20 Sep 04)
Net asset value (undiluted)-3.4%3.9%16.9%36.5%508.9%
Net asset value* (diluted)-3.4%4.1%16.9%36.5%509.1%
Share price-3.1%0.3%15.9%35.0%488.4%
FTSE World Europe ex UK-6.1%-3.3%-4.2%0.8%251.0%

* Diluted for treasury shares and subscription shares.Sources: BlackRock and Datastream. 

At month end

Net asset value (capital only):453.37p
Net asset value (including income):453.90p
Net asset value (capital only)1:453.37p
Net asset value (including income)1:453.90p
Share price:434.00p
Discount to NAV (including income):4.4%
Discount to NAV (including income)1:4.4%
Net gearing:10.1%
Net yield2:1.4%
Total assets (including income):382.7m
Ordinary shares in issue3:84,323,101
Ongoing charges4:1.0%

1 Diluted for treasury shares.2 Based on an interim dividend of 1.75p per share and a final dividend of 4.40p per share for the year ended 31 August 2020.3 Excluding 26,005,837 shares held in treasury.4 Calculated as a percentage of average net assets and using expenses, excluding interest costs, after relief for taxation, for the year ended 31 August 2020.

Sector AnalysisTotal Assets (%)Country AnalysisTotal Assets (%)
Technology24.1Denmark19.7
Industrials21.9Switzerland15.0
Health Care18.4Netherlands13.3
Consumer Goods11.2France13.3
Consumer Services8.5Germany7.1
Financials7.9Italy6.0
Basic Materials3.9Sweden5.4
Oil & Gas3.4Poland3.4
Telecommunications1.7United Kingdom3.4
Net Current Assets-1.0Israel2.7
-----Russia2.6
100.0Finland2.3
=====Spain2.3
Ireland2.3
Belgium2.0
Greece0.2
Net Current Assets-1.0
-----
100.0
=====

Top 10 HoldingsCountryFund %
SikaSwitzerland6.0
ASMLNetherlands5.9
KeringFrance5.1
Lonza GroupSwitzerland5.1
Novo NordiskDenmark5.0
Royal UnibrewDenmark4.7
DSVDenmark4.5
RELXUnited Kingdom3.3
HexagonSweden3.3
SafranFrance3.1

Commenting on the markets, Stefan Gries, representing the Investment Manager, noted:

During the month, the Company’s NAV fell by 3.4% and the share price declined by 3.1%. For reference, the FTSE World Europe ex UK Index returned -6.1% during the period.

Europe ex UK markets sold off during the month as surging coronavirus infection rates, as well as the reintroduction of national lockdowns in many European countries weighed on sentiment. While hospitalisation rates rise, we would note that increased hospital capacity and care and a better understanding of the virus have so far led to lower mortality rates than during the first wave. We believe the economic impact of a second lockdown is likely to be more muted this time around.

Many companies are now facing earnings downgrades in Q4 and Q1, but the overall market level is supported by the idea of a vaccine being announced in the near-term, as well as continued recovery in selective end markets going into 2021.

In October, defensive sectors such as telecommunications and utilities held up slightly better, while technology and oil & gas saw the sharpest market falls. The Company outperformed the reference index, driven by strong stock selection while sector allocation was negative.

In sector terms, the Company benefited from being overweight consumer services and industrials. Our higher exposure to technology detracted from returns, although this was more than offset by strong stock selection. While the Company’s higher allocation to healthcare – a sector that often experiences volatility ahead of US elections – detracted, this was also more than offset by accurate stock selection.

Stock selection was strongest within technology, where a new position in Allegro was the top performer over the month. This Polish e-commerce platform selling both international and local brands enjoyed a strong share price performance after only going public in early October. We believe the group’s growth prospects look strong over the medium to long term, as online penetration in the Polish retail market remains relatively low. Within the same sector, Netcompany and ASML were also amongst the strongest contributors.

The industrials sector contributed to relative returns with a holding in Sika being amongst the best performers, beating analyst expectations and raising guidance. The firm has rebounded quickly from considerably negative organic growth in Q2 to being flat in Q3, while also showing strong progression in margins.

French aerospace company Safran also reported strong Q3 numbers towards the end of the month and commentary on improving business trends was taken well by the market. Further, the company’s extensive cost cutting programme is running ahead of expectations. 

Stock selection within healthcare aided returns. Italian DiaSorin performed well given the launch of their COVID antigen test. Additionally, not owning Bayer was beneficial. The company issued a profit warning with the pandemic hitting profits harder than expected, forcing Bayer to write down the value of assets in its agricultural business.

Strong contribution also came from luxury brand Hermes which continued to benefit from the outstanding resilience of the high-end consumer. Within this context, not owning LVMH was negative as the company delivered strong Q3 results.

The Company’s investment in software group SAP was the largest detractor during October. The company published weaker than expected results and cut its revenue and profit forecasts for this year due to depressed business spending as coronavirus cases continue to rise. Importantly, SAP have updated medium term targets, essentially pushing them out by circa two years in part to reflect disruption caused by COVID. We had been expecting the management team to update the strategic targets in light of COVID, however were left surprised by the extent of the revision to forecasts.

A negative contribution also came from RELX which continues to see a COVID impact on their exhibitions business, as well as concerns around lower journals and subscription numbers from universities.

At the end of the period the Company had a higher allocation than the reference index towards technology, consumer services, industrials and health care. The Company had a neutral weighting towards oil & gas and underweight allocation to consumer goods, financials, utilities, basic materials and telecoms.

Outlook

Over recent years, many investors have avoided exposure to European equities owing to concerns around political risk, rising populism and a challenged financial system. We have long been of the view that one needs to take an active approach to investing in European equities. With this in mind, we felt that for active stock pickers Europe as a region can offer shareholders access to some highly attractive companies listed in the region. The response to the fallout from COVID-19 has the potential to change the more negative perception on the asset class as a whole.

The proposed €750 billion EU Recovery Fund is a significant step of solidarity for the bloc and one that can potentially bring greater fiscal coordination. In this context, both the economy and local stock markets appear well positioned to make up lost ground, potentially transforming European equities into a standout opportunity in the developed world, while notably providing further subsidies for growth in Emerging Europe.

18 November 2020

ENDS

Latest information is available by typing www.brgeplc.co.uk on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
3rd May 202412:40 pmPRNDirector/PDMR Shareholding
3rd May 202412:07 pmPRNNet Asset Value(s)
2nd May 20246:15 pmPRNHalf-year Report
2nd May 202412:04 pmPRNNet Asset Value(s)
1st May 202412:02 pmPRNNet Asset Value(s)
1st May 202410:12 amPRNTotal Voting Rights
30th Apr 202412:05 pmPRNNet Asset Value(s)
29th Apr 202412:23 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 202411:40 amPRNNet Asset Value(s)
25th Apr 20245:57 pmPRNTransaction in Own Shares
25th Apr 202412:09 pmPRNNet Asset Value(s)
24th Apr 20245:12 pmPRNPortfolio Update
24th Apr 202412:09 pmPRNNet Asset Value(s)
23rd Apr 202412:10 pmPRNNet Asset Value(s)
23rd Apr 20247:00 amPRNTotal Voting Rights
22nd Apr 202411:52 amPRNNet Asset Value(s)
19th Apr 20245:35 pmPRNTransaction in Own Shares
19th Apr 202412:04 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 202412:12 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20245:47 pmPRNTransaction in Own Shares
17th Apr 202412:11 pmPRNNet Asset Value(s)
16th Apr 20245:18 pmPRNTransaction in Own Shares
16th Apr 202411:58 amPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 202411:31 amPRNNet Asset Value(s)
12th Apr 20245:41 pmPRNTransaction in Own Shares
12th Apr 202412:10 pmPRNNet Asset Value(s)
11th Apr 202412:07 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 202411:59 amPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20245:25 pmPRNTransaction in Own Shares
9th Apr 202411:41 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:56 pmPRNTransaction in Own Shares
8th Apr 202411:54 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20246:53 pmPRNTransaction in Own Shares
5th Apr 202412:12 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights
4th Apr 20245:21 pmPRNTransaction in Own Shares
4th Apr 202411:59 amPRNNet Asset Value(s)
4th Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20246:27 pmPRNTransaction in Own Shares
3rd Apr 202412:02 pmPRNNet Asset Value(s)
3rd Apr 20247:00 amPRNTotal Voting Rights
2nd Apr 20245:37 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.